tert-Butyl 4-benzoylpiperidine-1-carboxylate
CAS: 193217-39-9
Ref. 3D-THA21739
| 25g | 3,130.00 € | ||
| 2500mg | 559.00 € |
Product Information
Tert-butyl 4-benzoylpiperidine-1-carboxylate (TBCPC) is a novel amide antagonist that has been shown to inhibit HIV entry into cells. TBCPC has been shown to have an oral bioavailability of 100% and a half-life of 10 hours in rats. This compound also had no effect on the pharmacokinetic profile of other drugs, which could make it a good candidate for replacing other anti-HIV drugs. TBCPC has the potential to be developed as a ccr5 antagonist and may have potential applications in treating diseases such as cancer, inflammatory bowel disease, and AIDS.
Chemical properties
Technical inquiry about: 3D-THA21739 tert-Butyl 4-benzoylpiperidine-1-carboxylate
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
